Herantis Pharma Oyj: Manager's Transactions - James Phillips
Herantis Pharma Plc
Company release 30 Aug 2018 at 9:00 am
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Phillips, James
Position: Member of the Board/Deputy member
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20180828114932_2
____________________________________________
Transaction date: 2018-08-29
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: Optio-ohjelma 2014 I (Optio- ja muut erityiset oikeudet P003)
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 6 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 6 Volume weighted average price: 0.00 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com